By synthesizing the outcomes of univariate analysis, LASSO regression, and multivariate logistic regression, and incorporating clinical expertise, the study identified age, smoking, diabetes, BMI, tumor location, lung metastasis, ALB, and CEA as independent risk factors for myelosuppression following first-line chemotherapy in CRC patients. This evidence concerns the gene CEACAM5 and neoplasm.